AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s.Scientists have created a drug that ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
As more neurons die, memory, thinking, and behaviour become increasingly impaired, leading to the cognitive decline seen in Alzheimer's. There are two specific 'hotspots' of the Tau protein where ...
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's ...
As more neurons die, memory, thinking, and behavior become increasingly impaired, leading to the cognitive decline seen in Alzheimer's. There are two specific "hotspots" of the tau protein where ...